Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company InVasc Therapeutics Inc.
DescriptionAngiotensin-converting enzyme (ACE) inhibitor combined with antioxidant nutraceutical
Molecular Target Angiotensin-converting enzyme (ACE)
Mechanism of ActionAngiotensin-converting enzyme (ACE) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetic nephropathy
Indication DetailsReduce proteinuria in hypertensive diabetic patients; Treat diabetic nephropathy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today